Clinical outcomes and safety of polymyxin B in the treatment of carbapenem-resistant Gram-negative bacterial infections: a real-world multicenter study

BACKGROUND: High morbidity and mortality due to carbapenem-resistant Gram-negative bacilli (CR-GNB) has led to the resurgence of polymyxin B (PMB) use in the last decade. The aim of our multicenter, real-world study was to evaluate the effectiveness and safety of PMB in the treatment of CR-GNB infec...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xiaojuan, Qi, Shaoyan, Duan, Xiaoguang, Han, Bing, Zhang, Shuguang, Liu, Shaohua, Wang, Haixu, Zhang, Haibo, Sun, Tongwen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8520283/
https://www.ncbi.nlm.nih.gov/pubmed/34656132
http://dx.doi.org/10.1186/s12967-021-03111-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8520283/
https://www.ncbi.nlm.nih.gov/pubmed/34656132
http://dx.doi.org/10.1186/s12967-021-03111-x

Ejemplares similares